Sun Pharma gets exclusive right to commercialise Winlevi acne cream in US, Canada

2021-08-31 15:14:15

and specialty pharma firm Cassiopea SpA on Tuesday announced consummation of their exclusive licence and supply agreements for Winlevi cream used for treatment of acne vulgaris in patients 12 years and older. The agreements are effective from August 31, 2021, according to a joint statement.

Sun Pharma now has the exclusive right to commercialise Winlevi in the US and Canada. Cassiopea will be the exclusive supplier of the product, which is expected to be available in the

Continue Reading